glyceraldehyde has been researched along with Acute Confusional Senile Dementia in 9 studies
Glyceraldehyde: An aldotriose containing the propionaldehyde structure with hydroxy groups at the 2- and 3-positions. It is involved in the formation of ADVANCED GLYCOSYLATION END PRODUCTS.
glyceraldehyde : An aldotriose comprising propanal having hydroxy groups at the 2- and 3-positions. It plays role in the formation of advanced glycation end-products (AGEs), a deleterious accompaniment to ageing.
aldose : Aldehydic parent sugars (polyhydroxy aldehydes H[CH(OH)]nC(=O)H, n >= 2) and their intramolecular hemiacetals.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we investigated the relationship between nervous system disorder and the pathogenesis of AD by exposing SH-SY5Y neuroblastoma cells to glyceraldehyde (GA)." | 7.96 | The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma Cells. ( Furukawa, A; Koriyama, Y; Nasu, R; Suzuki, K; Takeuchi, M, 2020) |
| " In order to investigate the relationship between impaired cerebral glucose metabolism and the pathophysiology of AD, SH-SY5Y human neuroblastoma cells were exposed to glyceraldehyde (GA), an inhibitor of glycolysis." | 7.81 | Glyceraldehyde caused Alzheimer's disease-like alterations in diagnostic marker levels in SH-SY5Y human neuroblastoma cells. ( Furukawa, A; Koriyama, Y; Muramatsu, M; Takeuchi, M; Takino, J, 2015) |
| " In this study, we investigated the relationship between nervous system disorder and the pathogenesis of AD by exposing SH-SY5Y neuroblastoma cells to glyceraldehyde (GA)." | 3.96 | The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma Cells. ( Furukawa, A; Koriyama, Y; Nasu, R; Suzuki, K; Takeuchi, M, 2020) |
| " In order to investigate the relationship between impaired cerebral glucose metabolism and the pathophysiology of AD, SH-SY5Y human neuroblastoma cells were exposed to glyceraldehyde (GA), an inhibitor of glycolysis." | 3.81 | Glyceraldehyde caused Alzheimer's disease-like alterations in diagnostic marker levels in SH-SY5Y human neuroblastoma cells. ( Furukawa, A; Koriyama, Y; Muramatsu, M; Takeuchi, M; Takino, J, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Piccirillo, S | 3 |
| Preziuso, A | 2 |
| Cerqueni, G | 1 |
| Serfilippi, T | 1 |
| Terenzi, V | 1 |
| Vinciguerra, A | 1 |
| Amoroso, S | 3 |
| Lariccia, V | 2 |
| Magi, S | 3 |
| Maiolino, M | 1 |
| Nasu, R | 1 |
| Furukawa, A | 2 |
| Suzuki, K | 1 |
| Takeuchi, M | 5 |
| Koriyama, Y | 2 |
| Giampieri, F | 1 |
| Cianciosi, D | 1 |
| Orciani, M | 1 |
| Muramatsu, M | 1 |
| Takino, J | 1 |
| Choei, H | 1 |
| Sasaki, N | 1 |
| Yoshida, T | 1 |
| Ukai, W | 1 |
| Yamagishi, S | 3 |
| Kikuchi, S | 2 |
| Saito, T | 1 |
| Nakamura, K | 1 |
| Inoue, H | 1 |
| Smith, MA | 1 |
| Rudnicka-Nawrot, M | 1 |
| Richey, PL | 1 |
| Praprotnik, D | 1 |
| Mulvihill, P | 1 |
| Miller, CA | 1 |
| Sayre, LM | 1 |
| Perry, G | 1 |
2 reviews available for glyceraldehyde and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
A strategic tool to improve the study of molecular determinants of Alzheimer's disease: The role of glyceraldehyde.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Glucose; Glycation End Products, Advanced; Glyceraldehyde; | 2023 |
Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.
Topics: Alzheimer Disease; Apoptosis; Brain; Diabetes Complications; Disease Progression; Glycation End Prod | 2008 |
7 other studies available for glyceraldehyde and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
NCX1 and EAAC1 transporters are involved in the protective action of glutamate in an in vitro Alzheimer's disease-like model.
Topics: Adenosine Triphosphate; Alzheimer Disease; Animals; Cell Death; Cell Differentiation; Cell Line, Tum | 2020 |
The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma Cells.
Topics: Alzheimer Disease; Cell Line, Tumor; Diabetes Mellitus; Disease Progression; Glucose; Glycation End | 2020 |
The Neuroprotective Effect of L-Carnitine against Glyceraldehyde-Induced Metabolic Impairment: Possible Implications in Alzheimer's Disease.
Topics: Adenosine Triphosphate; Alzheimer Disease; Animals; Carnitine; Cell Survival; Glyceraldehyde; Glycol | 2021 |
Glyceraldehyde caused Alzheimer's disease-like alterations in diagnostic marker levels in SH-SY5Y human neuroblastoma cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Glucose; Glycation End Products, Advance | 2015 |
Glyceraldehyde-derived advanced glycation end products in Alzheimer's disease.
Topics: Acetaldehyde; Aged; Alzheimer Disease; Brain; Glycation End Products, Advanced; Glyceraldehyde; Huma | 2004 |
Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.
Topics: Alzheimer Disease; Biomarkers; Diabetes Complications; Early Diagnosis; Glycation End Products, Adva | 2005 |
Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease.
Topics: Alzheimer Disease; Epitopes; Glyceraldehyde; Humans; Immunoblotting; Malondialdehyde; Microscopy, El | 1995 |